This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

OTTO LIPPMANN, M.D.

AMA Arch Ophthalmol. 1957;57(3):339-344.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

About a half a decade has elapsed since the introduction of the therapeutic use of corticosteroids. Experience has been accumulated as to their effectiveness in various ophthalmic diseases by systemic as well as by topical administration (Gordon, 1955¹⁶; Hogan, 1955⁸; Steffenson, 1955⁹). The splendid therapeutic responses have over-shadowed the local irritating effects of such topical preparations. Reports of such undesirable local side-effects are very brief, rare, and contradictory.

Previous Reports

The following citations from the literature will illustrate this point.

A. Older Reports Dealing with Cortisone.

—Woods, 1950¹: A 2.5% suspension without buffer "caused mild transient irritation which passed in a few minutes." Woods, 1951²: "This suspension" (in buffered vehicle with added preservative) "is completely non-irritating, in fact is somewhat soothing to an inflamed eye." Duke-Elder, 1951³: "This is completely non-irritating, even if the undiluted suspension is used." Leopold et al., 1951⁴: "There . . . [Full Text PDF of this Article]

Author Affiliations
Austin, Texas

From the Institute for Clinical Research.

Footnotes
Received for publication July 17, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?